Cephalon, Inc. Litigation, Intellectual Property, Attorneys, SEC Filings, and Other Public Records

Date Recorded	Party	Role	Document Type	Document No.	Invention Title

1/27/2025	Cephalon LLC	Assignee	Application Application Publication Publication Patent Patent	11983237 11104074 20050256133 20090018143 7297817 8071604	Thio-substituted Arylmethanesulfinyl Derivatives Thio-substituted Arylmethanesulfinyl Derivatives Thio-substituted Arylmethanesulfinyl Derivatives Thio-substituted Arylmethanesulfinyl Derivatives Thio-substituted Arylmethanesulfinyl Derivatives Thio-substituted Arylmethanesulfinyl Derivatives

12/9/2024	Teva Pharmaceuticals Australia Pty. Ltd.	Assignor	Application Publication	17815749 20230212281

12/9/2024	Cephalon LLC	Assignee	Application Publication	17815749 20230212281	Compositions And Methods For Anti-pacap Antibodies Compositions And Methods For Anti-pacap Antibodies

6/29/2023	Cephalon LLC	Assignee	Application Application Application Application Application Application Publication Publication Publication Publication Publication Publication Patent Patent Patent Patent	16471616 15267213 16164509 15659093 17647082 17538530 20170081400 20190106486 20180021696 20220127352 20220185902 20200270339 11267883 10138296 11220549 10688412	Antibodies That Specifically Bind To Human Il-15 And Uses Thereof Antibodies That Specifically Bind To TL1A Affinity Chromatography Wash Buffer Antibodies That Specifically Bind To TL1A and Methods of Treating Respir... Antibodies That Specifically Bind To Tl1a Antibodies That Specifically Bind To Human Il-15 And Uses Thereof Antibodies That Specifically Bind To TL1A Antibodies That Specifically Bind To Human Il-15 And Uses Thereof Affinity Chromatography Wash Buffer Antibodies That Specifically Bind To TL1A Antibodies That Specifically Bind To Tl1a Antibodies That Specifically Bind To Human Il-15 And Uses Thereof Antibodies That Specifically Bind To Human Il-15 And Uses Thereof Affinity Chromatography Wash Buffer Antibodies That Specifically Bind To TL1A Antibodies That Specifically Bind To Tl1a

6/29/2023	Cephalon LLC	Assignee	Application Application Application Application Application Application Publication Publication Publication Publication Publication Publication Patent Patent Patent Patent Patent	17538530 16471616 15267213 16164509 15659093 17647082 20170081400 20190106486 20180021696 20220127352 20220185902 20200270339 12162946 11267883 10138296 11220549 10688412	Antibodies That Specifically Bind To Human Il-15 And Uses Thereof Antibodies That Specifically Bind To TL1A Antibodies That Specifically Bind To Human Il-15 And Uses Thereof Affinity Chromatography Wash Buffer Antibodies That Specifically Bind To TL1A and Methods of Treating Respir... Antibodies That Specifically Bind To Tl1a Antibodies That Specifically Bind To Human Il-15 And Uses Thereof Antibodies That Specifically Bind To TL1A and Methods of Treating Gastro... Antibodies That Specifically Bind To Human Il-15 And Uses Thereof Affinity Chromatography Wash Buffer Antibodies That Specifically Bind To TL1A Antibodies That Specifically Bind To Tl1a Antibodies That Specifically Bind To Human Il-15 And Uses Thereof Antibodies That Specifically Bind To TL1A Affinity Chromatography Wash Buffer Antibodies That Specifically Bind To TL1A Antibodies That Specifically Bind To Tl1a

7/26/2022	Cephalon LLC	Assignee	Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application Publication Publication Publication ...and 44 more	10443327 11330868 13301979 13362430 13874575 17384350 13654898 13719379 13719409 13969724 17385532 14200738 17718622 14772540 15425421 15045523 15848090 15359777 16112016 16037560 16316451 16695624 16527354 10243557 20130041003 20130123316 20130131131 ...and 44 more	Pharmaceutical Prodrugs And Methods Of Their Preparation And Use Novel Pharmaceutical Formulations Of Modafinil Novel Solid Forms Of Bendamustine Hydrochloride Novel Solid Forms Of Bendamustine Hydrochloride Anti-cxcr2 Antibodies And Uses Thereof Bendamustine Pharmaceutical Compositions Pharmaceutical Prodrugs And Methods Of Their Preparation And Use Liquid Formulations Of Bendamustine Bendamustine Pharmaceutical Compositions Novel Solid Forms Of Bendamustine Hydrochloride Treatment Strategy For Non-responders To 100mg Subcutaneous Mepolizumab Novel Solid Forms Of Bendamustine Hydrochloride Bendamustine Pharmaceutical Compositions Novel Solid Forms Of Bendamustine Hydrochloride Anti-IL-5 Antibodies Bendamustine Pharmaceutical Compositions Bendamustine Pharmaceutical Compositions Novel Solid Forms Of Bendamustine Hydrochloride Nanoparticulate And Macroparticulate Formulations Preparations Of A Sulfinyl Acetamide Bendamustine Pharmaceutical Compositions Nanoparticulate And Macroparticulate Formulations Anti-cxcr2 Antibodies And Uses Thereof Novel Pharmaceutical Formulations Of Modafinil Novel Solid Forms Of Bendamustine Hydrochloride Anti-cxcr2 Antibodies And Uses Thereof Bendamustine Pharmaceutical Compositions ...and 44 more

3/8/2022	Pollard, Matthew	Assignor	Application Publication Patent	17538530 20220185902 12162946	Antibodies That Specifically Bind To TL1A Antibodies That Specifically Bind To TL1A and Methods of Treating Gastro... Antibodies That Specifically Bind To TL1A

3/8/2022	Doyle, Anthony G.	Assignor	Application Publication Patent	17538530 20220185902 12162946	Antibodies That Specifically Bind To TL1A Antibodies That Specifically Bind To TL1A and Methods of Treating Gastro... Antibodies That Specifically Bind To TL1A

3/8/2022	Clarke, Adam W.	Assignor	Application Publication Patent	17538530 20220185902 12162946	Antibodies That Specifically Bind To TL1A Antibodies That Specifically Bind To TL1A Antibodies That Specifically Bind To TL1A and Methods of Treating Gastro...

3/8/2022	Cooksey, Bridget A.	Assignor	Application Publication Patent	17538530 20220185902 12162946	Antibodies That Specifically Bind To TL1A Antibodies That Specifically Bind To TL1A and Methods of Treating Gastro... Antibodies That Specifically Bind To TL1A

3/8/2022	Poulton, Lynn Dorothy	Assignor	Application Publication Patent	17538530 20220185902 12162946	Antibodies That Specifically Bind To TL1A Antibodies That Specifically Bind To TL1A and Methods of Treating Gastro... Antibodies That Specifically Bind To TL1A

3/8/2022	Pande, Vanya	Assignor	Application Publication Patent	17538530 20220185902 12162946	Antibodies That Specifically Bind To TL1A Antibodies That Specifically Bind To TL1A and Methods of Treating Gastro... Antibodies That Specifically Bind To TL1A

1/7/2022	Pollard, Matthew	Assignor	Application Publication	17647082 20220127352	Antibodies That Specifically Bind To Human Il-15 And Uses Thereof Antibodies That Specifically Bind To Human Il-15 And Uses Thereof

1/7/2022	Doyle, Anthony Gerard	Assignor	Application Publication	17647082 20220127352	Antibodies That Specifically Bind To Human Il-15 And Uses Thereof Antibodies That Specifically Bind To Human Il-15 And Uses Thereof

1/7/2022	Clarke, Adam William	Assignor	Application Publication	17647082 20220127352	Antibodies That Specifically Bind To Human Il-15 And Uses Thereof Antibodies That Specifically Bind To Human Il-15 And Uses Thereof

1/7/2022	Poulton, Lynn Dorothy	Assignor	Application Publication	17647082 20220127352	Antibodies That Specifically Bind To Human Il-15 And Uses Thereof Antibodies That Specifically Bind To Human Il-15 And Uses Thereof

1/7/2022	Laine, David Jose Simon	Assignor	Application Publication	17647082 20220127352	Antibodies That Specifically Bind To Human Il-15 And Uses Thereof Antibodies That Specifically Bind To Human Il-15 And Uses Thereof

10/6/2020	Teva Branded Pharmaceutical Products R&d...	Assignor	Application Publication Patent	16468960 20200095316 10906973	Antibody Variants Transmigrating The Blood-brain Barrier And Uses Thereo... Antibody Variants Transmigrating The Blood-brain Barrier And Uses Thereo... Antibody Variants Transmigrating The Blood-brain Barrier And Uses Thereo...

10/6/2020	Teva Pharmaceuticals Australia Pty Ltd.	Assignor	Application Publication Patent	16468960 20200095316 10906973	Antibody Variants Transmigrating The Blood-brain Barrier And Uses Thereo... Antibody Variants Transmigrating The Blood-brain Barrier And Uses Thereo... Antibody Variants Transmigrating The Blood-brain Barrier And Uses Thereo...

5/15/2020	Pollard, Matthew	Assignor	Application Publication	16471616 20200270339	Antibodies That Specifically Bind To Human Il-15 And Uses Thereof Antibodies That Specifically Bind To Human Il-15 And Uses Thereof

5/15/2020	Doyle, Anthony Gerard	Assignor	Application Publication	16471616 20200270339	Antibodies That Specifically Bind To Human Il-15 And Uses Thereof Antibodies That Specifically Bind To Human Il-15 And Uses Thereof

5/15/2020	Clarke, Adam William	Assignor	Application Publication	16471616 20200270339	Antibodies That Specifically Bind To Human Il-15 And Uses Thereof Antibodies That Specifically Bind To Human Il-15 And Uses Thereof

5/15/2020	Poulton, Lynn Dorothy	Assignor	Application Publication	16471616 20200270339	Antibodies That Specifically Bind To Human Il-15 And Uses Thereof Antibodies That Specifically Bind To Human Il-15 And Uses Thereof

5/15/2020	Laine, David Jose Simon	Assignor	Application Publication	16471616 20200270339	Antibodies That Specifically Bind To Human Il-15 And Uses Thereof Antibodies That Specifically Bind To Human Il-15 And Uses Thereof

5/15/2020	Pollard, Matthew	Assignor	Application Publication Patent	16471616 20200270339 11267883	Antibodies That Specifically Bind To Human Il-15 And Uses Thereof Antibodies That Specifically Bind To Human Il-15 And Uses Thereof Antibodies That Specifically Bind To Human Il-15 And Uses Thereof

5/15/2020	Doyle, Anthony Gerard	Assignor	Application Publication Patent	16471616 20200270339 11267883	Antibodies That Specifically Bind To Human Il-15 And Uses Thereof Antibodies That Specifically Bind To Human Il-15 And Uses Thereof Antibodies That Specifically Bind To Human Il-15 And Uses Thereof

5/15/2020	Clarke, Adam William	Assignor	Application Publication Patent	16471616 20200270339 11267883	Antibodies That Specifically Bind To Human Il-15 And Uses Thereof Antibodies That Specifically Bind To Human Il-15 And Uses Thereof Antibodies That Specifically Bind To Human Il-15 And Uses Thereof

5/15/2020	Poulton, Lynn Dorothy	Assignor	Application Publication Patent	16471616 20200270339 11267883	Antibodies That Specifically Bind To Human Il-15 And Uses Thereof Antibodies That Specifically Bind To Human Il-15 And Uses Thereof Antibodies That Specifically Bind To Human Il-15 And Uses Thereof

5/15/2020	Laine, David Jose Simon	Assignor	Application Publication Patent	16471616 20200270339 11267883	Antibodies That Specifically Bind To Human Il-15 And Uses Thereof Antibodies That Specifically Bind To Human Il-15 And Uses Thereof Antibodies That Specifically Bind To Human Il-15 And Uses Thereof

3/10/2020	Mcmaster University	Assignor	Application Publication	16112016 20190062421

3/10/2020	Mcmaster University	Assignor	Application Publication Patent	16112016 20190062421 11224653	Treatment Strategy For Non-responders To 100mg Subcutaneous Mepolizumab Treatment Strategy For Non-responders To 100mg Subcutaneous Mepolizumab Treatment Strategy For Non-responders To 100mg Subcutaneous Mepolizumab

8/16/2019	Yazdanian, Mehran	Assignor	Application Publication	16156718 20190071449	Solid State Forms Of Spiro-oxindole Compounds Solid State Forms Of Spiro-oxindole Compounds

8/16/2019	Bierlmaier, Stephen	Assignor	Application Publication	16156718 20190071449	Solid State Forms Of Spiro-oxindole Compounds Solid State Forms Of Spiro-oxindole Compounds

8/16/2019	Haltiwanger, Ralph Curtis	Assignor	Application Publication	16156718 20190071449	Solid State Forms Of Spiro-oxindole Compounds Solid State Forms Of Spiro-oxindole Compounds

8/16/2019	Wu, Raeann Ruiyun	Assignor	Application Publication	16156718 20190071449	Solid State Forms Of Spiro-oxindole Compounds Solid State Forms Of Spiro-oxindole Compounds

8/16/2019	Teva Pharmaceuticals International GmbH	Assignee	Application Publication	16156718 20190071449

8/16/2019	Yazdanian, Mehran	Assignor	Application Publication Patent	16156718 20190071449 10513526	Solid State Forms Of Spiro-oxindole Compounds Solid State Forms Of Spiro-oxindole Compounds Solid State Forms Of Spiro-oxindole Compounds

8/16/2019	Bierlmaier, Stephen	Assignor	Application Publication Patent	16156718 20190071449 10513526	Solid State Forms Of Spiro-oxindole Compounds Solid State Forms Of Spiro-oxindole Compounds Solid State Forms Of Spiro-oxindole Compounds

8/16/2019	Haltiwanger, Ralph Curtis	Assignor	Application Publication Patent	16156718 20190071449 10513526	Solid State Forms Of Spiro-oxindole Compounds Solid State Forms Of Spiro-oxindole Compounds Solid State Forms Of Spiro-oxindole Compounds

8/16/2019	Wu, Raeann Ruiyun	Assignor	Application Publication Patent	16156718 20190071449 10513526	Solid State Forms Of Spiro-oxindole Compounds Solid State Forms Of Spiro-oxindole Compounds Solid State Forms Of Spiro-oxindole Compounds

8/16/2019	Teva Pharmaceuticals International GmbH	Assignee	Application Publication Patent	16156718 20190071449 10513526	Solid State Forms Of Spiro-oxindole Compounds Solid State Forms Of Spiro-oxindole Compounds Solid State Forms Of Spiro-oxindole Compounds

7/2/2019	Mcwherter, Melody	Assignor	Application Publication	16469840 20200031840	Spiropiperidine Derivatives Spiropiperidine Derivatives

6/14/2019	Hudkins, Robert L.	Assignor	Application Publication	16469840 20200031840	Spiropiperidine Derivatives Spiropiperidine Derivatives

6/14/2019	Whitman, David B.	Assignor	Application Publication	16469840 20200031840	Spiropiperidine Derivatives Spiropiperidine Derivatives

6/14/2019	Zulli, Allison L.	Assignor	Application Publication	16469840 20200031840	Spiropiperidine Derivatives Spiropiperidine Derivatives

6/14/2019	Zificsak, Craig A.	Assignor	Application Publication	16469840 20200031840	Spiropiperidine Derivatives Spiropiperidine Derivatives

6/14/2019	89bio Ltd	Assignee	Application Publication	16469840 20200031840	Spiropiperidine Derivatives Spiropiperidine Derivatives

2/15/2019	Jacobs, Martin J.	Assignor	Application Publication	16172368 20190328735	Fused Bicyclic 2,4-Diaminopyrimidine Derivative as a Dual ALK and FAK In... Fused Bicyclic 2,4-Diaminopyrimidine Derivative as a Dual ALK and FAK In...

2/15/2019	Ott, Gregory R.	Assignor	Application Publication	16172368 20190328735	Fused Bicyclic 2,4-Diaminopyrimidine Derivative as a Dual ALK and FAK In... Fused Bicyclic 2,4-Diaminopyrimidine Derivative as a Dual ALK and FAK In...

2/15/2019	Courvoisier, Laurent	Assignor	Application Publication	16172368 20190328735	Fused Bicyclic 2,4-Diaminopyrimidine Derivative as a Dual ALK and FAK In... Fused Bicyclic 2,4-Diaminopyrimidine Derivative as a Dual ALK and FAK In...

2/15/2019	Allwein, Shawn P.	Assignor	Application Publication	16172368 20190328735	Fused Bicyclic 2,4-Diaminopyrimidine Derivative as a Dual ALK and FAK In... Fused Bicyclic 2,4-Diaminopyrimidine Derivative as a Dual ALK and FAK In...

2/15/2019	Jacobs, Martin J.	Assignor	Application Publication Patent	16172368 20190328735 10632119	Fused Bicyclic 2,4-Diaminopyrimidine Derivative as a Dual ALK and FAK In... Fused Bicyclic 2,4-Diaminopyrimidine Derivative as a Dual ALK and FAK In... Fused Bicyclic 2,4-Diaminopyrimidine Derivative as a Dual ALK and FAK In...

2/15/2019	Ott, Gregory R.	Assignor	Application Publication Patent	16172368 20190328735 10632119	Fused Bicyclic 2,4-Diaminopyrimidine Derivative as a Dual ALK and FAK In... Fused Bicyclic 2,4-Diaminopyrimidine Derivative as a Dual ALK and FAK In... Fused Bicyclic 2,4-Diaminopyrimidine Derivative as a Dual ALK and FAK In...

2/15/2019	Courvoisier, Laurent	Assignor	Application Publication Patent	16172368 20190328735 10632119	Fused Bicyclic 2,4-Diaminopyrimidine Derivative as a Dual ALK and FAK In... Fused Bicyclic 2,4-Diaminopyrimidine Derivative as a Dual ALK and FAK In... Fused Bicyclic 2,4-Diaminopyrimidine Derivative as a Dual ALK and FAK In...

2/15/2019	Allwein, Shawn P.	Assignor	Application Publication Patent	16172368 20190328735 10632119	Fused Bicyclic 2,4-Diaminopyrimidine Derivative as a Dual ALK and FAK In... Fused Bicyclic 2,4-Diaminopyrimidine Derivative as a Dual ALK and FAK In... Fused Bicyclic 2,4-Diaminopyrimidine Derivative as a Dual ALK and FAK In...

1/18/2019	Learn, Keith S.	Assignor	Application Application Publication Publication Patent	15417191 16212582 20170158706 20190106433 10183950	Thienopyrimidine Inhibitors Of Atypical Protein Kinase C Thienopyrimidine Inhibitors Of Atypical Protein Kinase C Thienopyrimidine Inhibitors Of Atypical Protein Kinase C Thienopyrimidine Inhibitors Of Atypical Protein Kinase C Thienopyrimidine Inhibitors Of Atypical Protein Kinase C

1/18/2019	Dorsey, Bruce D.	Assignor	Application Application Publication Publication Patent	15417191 16212582 20170158706 20190106433 10183950	Thienopyrimidine Inhibitors Of Atypical Protein Kinase C Thienopyrimidine Inhibitors Of Atypical Protein Kinase C Thienopyrimidine Inhibitors Of Atypical Protein Kinase C Thienopyrimidine Inhibitors Of Atypical Protein Kinase C Thienopyrimidine Inhibitors Of Atypical Protein Kinase C

1/18/2019	Ott, Gregory R.	Assignor	Application Application Publication Publication Patent	15417191 16212582 20170158706 20190106433 10183950	Thienopyrimidine Inhibitors Of Atypical Protein Kinase C Thienopyrimidine Inhibitors Of Atypical Protein Kinase C Thienopyrimidine Inhibitors Of Atypical Protein Kinase C Thienopyrimidine Inhibitors Of Atypical Protein Kinase C Thienopyrimidine Inhibitors Of Atypical Protein Kinase C

1/18/2019	Wagner, Jason C.	Assignor	Application Application Publication Publication Patent	15417191 16212582 20170158706 20190106433 10183950	Thienopyrimidine Inhibitors Of Atypical Protein Kinase C Thienopyrimidine Inhibitors Of Atypical Protein Kinase C Thienopyrimidine Inhibitors Of Atypical Protein Kinase C Thienopyrimidine Inhibitors Of Atypical Protein Kinase C Thienopyrimidine Inhibitors Of Atypical Protein Kinase C

1/18/2019	Morris, Emma L.	Assignor	Application Application Publication Publication Patent	15417191 16212582 20170158706 20190106433 10183950	Thienopyrimidine Inhibitors Of Atypical Protein Kinase C Thienopyrimidine Inhibitors Of Atypical Protein Kinase C Thienopyrimidine Inhibitors Of Atypical Protein Kinase C Thienopyrimidine Inhibitors Of Atypical Protein Kinase C Thienopyrimidine Inhibitors Of Atypical Protein Kinase C

1/18/2019	Roffey, Jonathan R.a.	Assignor	Application Application Publication Publication Patent	15417191 16212582 20170158706 20190106433 10183950	Thienopyrimidine Inhibitors Of Atypical Protein Kinase C Thienopyrimidine Inhibitors Of Atypical Protein Kinase C Thienopyrimidine Inhibitors Of Atypical Protein Kinase C Thienopyrimidine Inhibitors Of Atypical Protein Kinase C Thienopyrimidine Inhibitors Of Atypical Protein Kinase C

1/18/2019	Soudy, Christelle N.	Assignor	Application Application Publication Publication Patent	15417191 16212582 20170158706 20190106433 10183950	Thienopyrimidine Inhibitors Of Atypical Protein Kinase C Thienopyrimidine Inhibitors Of Atypical Protein Kinase C Thienopyrimidine Inhibitors Of Atypical Protein Kinase C Thienopyrimidine Inhibitors Of Atypical Protein Kinase C Thienopyrimidine Inhibitors Of Atypical Protein Kinase C

1/18/2019	Ignyta, Inc.	Assignee	Application Application Publication Publication Patent	15417191 16212582 20170158706 20190106433 10183950	Thienopyrimidine Inhibitors Of Atypical Protein Kinase C Thienopyrimidine Inhibitors Of Atypical Protein Kinase C Thienopyrimidine Inhibitors Of Atypical Protein Kinase C Thienopyrimidine Inhibitors Of Atypical Protein Kinase C Thienopyrimidine Inhibitors Of Atypical Protein Kinase C

1/18/2019	Learn, Keith S.	Assignor	Application Application Publication Publication Patent Patent	15417191 16212582 20170158706 20190106433 10183950 10954251	Thienopyrimidine Inhibitors Of Atypical Protein Kinase C Thienopyrimidine Inhibitors Of Atypical Protein Kinase C Thienopyrimidine Inhibitors Of Atypical Protein Kinase C Thienopyrimidine Inhibitors Of Atypical Protein Kinase C Thienopyrimidine Inhibitors Of Atypical Protein Kinase C Thienopyrimidine Inhibitors Of Atypical Protein Kinase C

1/18/2019	Dorsey, Bruce D.	Assignor	Application Application Publication Publication Patent Patent	15417191 16212582 20170158706 20190106433 10183950 10954251	Thienopyrimidine Inhibitors Of Atypical Protein Kinase C Thienopyrimidine Inhibitors Of Atypical Protein Kinase C Thienopyrimidine Inhibitors Of Atypical Protein Kinase C Thienopyrimidine Inhibitors Of Atypical Protein Kinase C Thienopyrimidine Inhibitors Of Atypical Protein Kinase C Thienopyrimidine Inhibitors Of Atypical Protein Kinase C

1/18/2019	Ott, Gregory R.	Assignor	Application Application Publication Publication Patent Patent	15417191 16212582 20190106433 20170158706 10183950 10954251	Thienopyrimidine Inhibitors Of Atypical Protein Kinase C Thienopyrimidine Inhibitors Of Atypical Protein Kinase C Thienopyrimidine Inhibitors Of Atypical Protein Kinase C Thienopyrimidine Inhibitors Of Atypical Protein Kinase C Thienopyrimidine Inhibitors Of Atypical Protein Kinase C Thienopyrimidine Inhibitors Of Atypical Protein Kinase C

1/18/2019	Wagner, Jason C.	Assignor	Application Application Publication Publication Patent Patent	15417191 16212582 20170158706 20190106433 10183950 10954251	Thienopyrimidine Inhibitors Of Atypical Protein Kinase C Thienopyrimidine Inhibitors Of Atypical Protein Kinase C Thienopyrimidine Inhibitors Of Atypical Protein Kinase C Thienopyrimidine Inhibitors Of Atypical Protein Kinase C Thienopyrimidine Inhibitors Of Atypical Protein Kinase C Thienopyrimidine Inhibitors Of Atypical Protein Kinase C

1/18/2019	Morris, Emma L.	Assignor	Application Application Publication Publication Patent Patent	15417191 16212582 20170158706 20190106433 10183950 10954251	Thienopyrimidine Inhibitors Of Atypical Protein Kinase C Thienopyrimidine Inhibitors Of Atypical Protein Kinase C Thienopyrimidine Inhibitors Of Atypical Protein Kinase C Thienopyrimidine Inhibitors Of Atypical Protein Kinase C Thienopyrimidine Inhibitors Of Atypical Protein Kinase C Thienopyrimidine Inhibitors Of Atypical Protein Kinase C

1/18/2019	Roffey, Jonathan R.a.	Assignor	Application Application Publication Publication Patent Patent	15417191 16212582 20170158706 20190106433 10183950 10954251	Thienopyrimidine Inhibitors Of Atypical Protein Kinase C Thienopyrimidine Inhibitors Of Atypical Protein Kinase C Thienopyrimidine Inhibitors Of Atypical Protein Kinase C Thienopyrimidine Inhibitors Of Atypical Protein Kinase C Thienopyrimidine Inhibitors Of Atypical Protein Kinase C Thienopyrimidine Inhibitors Of Atypical Protein Kinase C

1/18/2019	Soudy, Christelle N.	Assignor	Application Application Publication Publication Patent Patent	15417191 16212582 20170158706 20190106433 10183950 10954251	Thienopyrimidine Inhibitors Of Atypical Protein Kinase C Thienopyrimidine Inhibitors Of Atypical Protein Kinase C Thienopyrimidine Inhibitors Of Atypical Protein Kinase C Thienopyrimidine Inhibitors Of Atypical Protein Kinase C Thienopyrimidine Inhibitors Of Atypical Protein Kinase C Thienopyrimidine Inhibitors Of Atypical Protein Kinase C

1/18/2019	Ignyta, Inc.	Assignee	Application Application Publication Publication Patent Patent	15417191 16212582 20170158706 20190106433 10183950 10954251	Thienopyrimidine Inhibitors Of Atypical Protein Kinase C Thienopyrimidine Inhibitors Of Atypical Protein Kinase C Thienopyrimidine Inhibitors Of Atypical Protein Kinase C Thienopyrimidine Inhibitors Of Atypical Protein Kinase C Thienopyrimidine Inhibitors Of Atypical Protein Kinase C Thienopyrimidine Inhibitors Of Atypical Protein Kinase C

1/10/2019	Pollard, Matthew	Assignor	Application Publication	16164509 20190106486	Antibodies That Specifically Bind To TL1A Antibodies That Specifically Bind To TL1A

1/10/2019	Doyle, Anthony G.	Assignor	Application Publication	16164509 20190106486	Antibodies That Specifically Bind To TL1A Antibodies That Specifically Bind To TL1A

1/10/2019	Clarke, Adam William	Assignor	Application Publication	16164509 20190106486	Antibodies That Specifically Bind To TL1A Antibodies That Specifically Bind To TL1A

1/10/2019	Poulton, Lynn Dorothy	Assignor	Application Publication	16164509 20190106486	Antibodies That Specifically Bind To TL1A Antibodies That Specifically Bind To TL1A

1/10/2019	Cooksey, Bridget Ann	Assignor	Application Publication	16164509 20190106486	Antibodies That Specifically Bind To TL1A Antibodies That Specifically Bind To TL1A

1/10/2019	Pande, Vanya	Assignor	Application Publication	16164509 20190106486	Antibodies That Specifically Bind To TL1A Antibodies That Specifically Bind To TL1A

1/10/2019	Pollard, Matthew	Assignor	Application Publication Patent	16164509 20190106486 11220549	Antibodies That Specifically Bind To TL1A Antibodies That Specifically Bind To TL1A and Methods of Treating Respir... Antibodies That Specifically Bind To TL1A

1/10/2019	Doyle, Anthony G.	Assignor	Application Publication Patent	16164509 20190106486 11220549	Antibodies That Specifically Bind To TL1A Antibodies That Specifically Bind To TL1A and Methods of Treating Respir... Antibodies That Specifically Bind To TL1A

1/10/2019	Clarke, Adam William	Assignor	Application Publication Patent	16164509 20190106486 11220549	Antibodies That Specifically Bind To TL1A Antibodies That Specifically Bind To TL1A and Methods of Treating Respir... Antibodies That Specifically Bind To TL1A

1/10/2019	Poulton, Lynn Dorothy	Assignor	Application Publication Patent	16164509 20190106486 11220549	Antibodies That Specifically Bind To TL1A Antibodies That Specifically Bind To TL1A and Methods of Treating Respir... Antibodies That Specifically Bind To TL1A

1/10/2019	Cooksey, Bridget Ann	Assignor	Application Publication Patent	16164509 20190106486 11220549	Antibodies That Specifically Bind To TL1A Antibodies That Specifically Bind To TL1A Antibodies That Specifically Bind To TL1A and Methods of Treating Respir...

1/10/2019	Pande, Vanya	Assignor	Application Publication Patent	16164509 20190106486 11220549	Antibodies That Specifically Bind To TL1A Antibodies That Specifically Bind To TL1A Antibodies That Specifically Bind To TL1A and Methods of Treating Respir...

1/9/2019	Drager, Anthony S.	Assignor	Application Publication	16316451 20190240348	Pharmaceutical Prodrugs And Methods Of Their Preparation And Use Pharmaceutical Prodrugs And Methods Of Their Preparation And Use

1/9/2019	Wattamwar, Paritosh	Assignor	Application Publication	16316451 20190240348	Pharmaceutical Prodrugs And Methods Of Their Preparation And Use Pharmaceutical Prodrugs And Methods Of Their Preparation And Use

11/1/2018	Wang, Lu	Assignor	Application Publication	16014778 20190046956	Cation Exchange Chromatography Wash Buffer Cation Exchange Chromatography Wash Buffer

11/1/2018	Zhang, Zhaoqing	Assignor	Application Publication	16014778 20190046956	Cation Exchange Chromatography Wash Buffer Cation Exchange Chromatography Wash Buffer

11/1/2018	Jin, Mi	Assignor	Application Publication	16014778 20190046956	Cation Exchange Chromatography Wash Buffer Cation Exchange Chromatography Wash Buffer

11/1/2018	Zhou, Tianyi	Assignor	Application Publication	16014778 20190046956	Cation Exchange Chromatography Wash Buffer Cation Exchange Chromatography Wash Buffer

11/1/2018	Kao, Albert	Assignor	Application Publication	16014778 20190046956	Cation Exchange Chromatography Wash Buffer Cation Exchange Chromatography Wash Buffer

10/4/2018	89bio Ltd	Assignee	Application Application Publication Publication Patent	15185710 15903150 20160368874 20180179159 9902696	1,4-substituted Piperidine Derivatives 1,4-substituted Piperidine Derivatives 1,4-substituted Piperidine Derivatives 1,4-substituted Piperidine Derivatives 1,4-substituted Piperidine Derivatives

10/4/2018	89bio Ltd	Assignee	Application Application Publication Publication Patent Patent	15185710 15903150 20160368874 20180179159 9902696 10221135	1,4-substituted Piperidine Derivatives 1,4-substituted Piperidine Derivatives 1,4-substituted Piperidine Derivatives 1,4-substituted Piperidine Derivatives 1,4-substituted Piperidine Derivatives 1,4-substituted Piperidine Derivatives

10/4/2018	89bio Ltd	Assignee	Application Application Application Publication Publication Publication Patent Patent Patent	15735811 15185710 15903150 20160368874 20180179159 20200031797 9902696 10221135 10919875	1,4-substituted Piperidine Derivatives 1,4-substituted Piperidine Derivatives Substituted 4-benzyl And 4-benzoyl Piperidine Derivatives 1,4-substituted Piperidine Derivatives 1,4-substituted Piperidine Derivatives Substituted 4-benzyl And 4-benzoyl Piperidine Derivatives 1,4-substituted Piperidine Derivatives 1,4-substituted Piperidine Derivatives Substituted 4-benzyl And 4-benzoyl Piperidine Derivatives

8/1/2018	Hudkins, Robert L.	Assignor	Application Publication	16018847 20190151317	METHODS OF TREATING VARIOUS CANCERS USING AN AXL/cMET INHIBITOR ALONE OR... METHODS OF TREATING VARIOUS CANCERS USING AN AXL/cMET INHIBITOR ALONE OR...

8/1/2018	Dorsey, Bruce D.	Assignor	Application Publication	16018847 20190151317	METHODS OF TREATING VARIOUS CANCERS USING AN AXL/cMET INHIBITOR ALONE OR... METHODS OF TREATING VARIOUS CANCERS USING AN AXL/cMET INHIBITOR ALONE OR...

8/1/2018	Ator, Mark A.	Assignor	Application Publication	16018847 20190151317	METHODS OF TREATING VARIOUS CANCERS USING AN AXL/cMET INHIBITOR ALONE OR... METHODS OF TREATING VARIOUS CANCERS USING AN AXL/cMET INHIBITOR ALONE OR...

8/1/2018	Ruggeri, Bruce A.	Assignor	Application Publication	16018847 20190151317	METHODS OF TREATING VARIOUS CANCERS USING AN AXL/cMET INHIBITOR ALONE OR... METHODS OF TREATING VARIOUS CANCERS USING AN AXL/cMET INHIBITOR ALONE OR...

8/1/2018	Angeles, Thelma S.	Assignor	Application Publication	16018847 20190151317	METHODS OF TREATING VARIOUS CANCERS USING AN AXL/cMET INHIBITOR ALONE OR... METHODS OF TREATING VARIOUS CANCERS USING AN AXL/cMET INHIBITOR ALONE OR...

8/1/2018	Cheng, Mangeng M.	Assignor	Application Publication	16018847 20190151317	METHODS OF TREATING VARIOUS CANCERS USING AN AXL/cMET INHIBITOR ALONE OR... METHODS OF TREATING VARIOUS CANCERS USING AN AXL/cMET INHIBITOR ALONE OR...

8/1/2018	Ignyta, Inc.	Assignee	Application Publication	16018847 20190151317

7/20/2018	O'brien, Christopher	Assignor	Application Publication	15783289 20180030131

7/20/2018	Shah, Tushar	Assignor	Application Publication	15783289 20180030131

7/20/2018	Zangrilli, James	Assignor	Application Publication	15783289 20180030131

7/20/2018	Universiteit Gent	Assignor	Application Publication	15783289 20180030131

7/20/2018	O'brien, Christopher	Assignor	Application Publication Application	15783289 20180030131 10577414	Use of Reslizumab to Treat Moderate to Severe Eosinophilic Asthma Use of Reslizumab to Treat Moderate to Severe Eosinophilic Asthma

7/20/2018	Shah, Tushar	Assignor	Application Publication Application	15783289 20180030131 10577414	Use of Reslizumab to Treat Moderate to Severe Eosinophilic Asthma Use of Reslizumab to Treat Moderate to Severe Eosinophilic Asthma

7/20/2018	Zangrilli, James	Assignor	Application Publication Application	15783289 20180030131 10577414	Use of Reslizumab to Treat Moderate to Severe Eosinophilic Asthma Use of Reslizumab to Treat Moderate to Severe Eosinophilic Asthma

7/20/2018	Universiteit Gent	Assignor	Application Publication Application	15783289 20180030131 10577414	Use of Reslizumab to Treat Moderate to Severe Eosinophilic Asthma Use of Reslizumab to Treat Moderate to Severe Eosinophilic Asthma

6/5/2018	Chen, Jian	Assignor	Application Publication	15879130 20180147186	Bendamustine Derivatives And Methods Of Using Same Bendamustine Derivatives And Methods Of Using Same

6/5/2018	Bakale, Roger P.	Assignor	Application Publication	15879130 20180147186	Bendamustine Derivatives And Methods Of Using Same Bendamustine Derivatives And Methods Of Using Same

6/5/2018	Roemmele, Renee C.	Assignor	Application Publication	15879130 20180147186	Bendamustine Derivatives And Methods Of Using Same Bendamustine Derivatives And Methods Of Using Same

6/5/2018	Patel, Piyush R.	Assignor	Application Publication	15879130 20180147186	Bendamustine Derivatives And Methods Of Using Same Bendamustine Derivatives And Methods Of Using Same

6/5/2018	Drager, Anthony S.	Assignor	Application Publication	15879130 20180147186	Bendamustine Derivatives And Methods Of Using Same Bendamustine Derivatives And Methods Of Using Same

6/5/2018	Mckean, Robert E.	Assignor	Application Publication	15879130 20180147186	Bendamustine Derivatives And Methods Of Using Same Bendamustine Derivatives And Methods Of Using Same

6/5/2018	Labell, Rachel Y.	Assignor	Application Publication	15879130 20180147186	Bendamustine Derivatives And Methods Of Using Same Bendamustine Derivatives And Methods Of Using Same

6/5/2018	Brown, Peter D.	Assignor	Application Publication	15879130 20180147186

6/5/2018	Chen, Jian	Assignor	Application Publication	15879130 20180147186

6/5/2018	Bakale, Roger P.	Assignor	Application Publication	15879130 20180147186

6/5/2018	Roemmele, Renee C.	Assignor	Application Publication	15879130 20180147186

6/5/2018	Patel, Piyush R.	Assignor	Application Publication	15879130 20180147186

6/5/2018	Drager, Anthony S.	Assignor	Application Publication	15879130 20180147186

6/5/2018	Mckean, Robert E.	Assignor	Application Publication	15879130 20180147186

6/5/2018	Labell, Rachel Y.	Assignor	Application Publication	15879130 20180147186

6/5/2018	Ignyta, Inc.	Assignee	Application Publication	15879130 20180147186

4/12/2018	Ott, Gregory R.	Assignor	Application Publication	15767768 20180305298	Deuterated Chlorokynurenines For The Treatment Of Neuropsychiatric Disor... Deuterated Chlorokynurenines For The Treatment Of Neuropsychiatric Disor...

4/12/2018	Auspex Pharmaceuticals, Inc.	Assignee	Application Publication	15767768 20180305298

4/3/2018	Hudkins, Robert L	Assignor	Application Publication	15879175 20180148447	Pyrazolo[1,5-a]pyridine Derivatives And Methods Of Their Use Pyrazolo[1,5-a]pyridine Derivatives And Methods Of Their Use

4/3/2018	Zulli, Allison L	Assignor	Application Publication	15879175 20180148447	Pyrazolo[1,5-a]pyridine Derivatives And Methods Of Their Use Pyrazolo[1,5-a]pyridine Derivatives And Methods Of Their Use

4/3/2018	Ignyta, Inc.	Assignee	Application Publication	15879175 20180148447

3/22/2018	Teva Pharmaceutical Industries, Ltd.	Assignor	Application Publication	15756692 20180327351

3/22/2018	Ott, Gregory R.	Assignor	Application Publication	15756692 20180327351

3/7/2018	Pollard, Matthew	Assignor	Application Publication	15267213 20170081400	Antibodies That Specifically Bind To Tl1a Antibodies That Specifically Bind To Tl1a

3/7/2018	Doyle, Anthony G.	Assignor	Application Publication	15267213 20170081400	Antibodies That Specifically Bind To Tl1a Antibodies That Specifically Bind To Tl1a

3/7/2018	Clarke, Adam William	Assignor	Application Publication	15267213 20170081400	Antibodies That Specifically Bind To Tl1a Antibodies That Specifically Bind To Tl1a

3/7/2018	Poulton, Lynn Dorothy	Assignor	Application Publication	15267213 20170081400	Antibodies That Specifically Bind To Tl1a Antibodies That Specifically Bind To Tl1a

3/7/2018	Cooksey, Bridget Ann	Assignor	Application Publication	15267213 20170081400	Antibodies That Specifically Bind To Tl1a Antibodies That Specifically Bind To Tl1a

3/7/2018	Pande, Vanya	Assignor	Application Publication	15267213 20170081400	Antibodies That Specifically Bind To Tl1a Antibodies That Specifically Bind To Tl1a

137 Rows Total

Cephalon, Inc. CEPH